Portable
Our device will sit on a small platform, small enough to be carried in one hand.
Lacoustic
Lacoustic
The model involves developing licensing it out the LCAT devices to various labs and institutions. This model makes the most sense as licensing revenues allow for long time return on investments. We aim to keep qunique position due to the patent on the LCAT technology. This means others can't undercut our pricing with imitation products giving us more market space.
As the image to the left shows, platform based businesses have been a growing trend around the world (especially in the biomdeical field) and Lacousitc hope to take advantage of this.
There are a variety of avenues that we can pursue .
Venture Capitalists will also demand a fair amount of control over our operations and decision-making, but we think that they can provide a valuable resource. The VC would also help with management, promotion and providing contacts. A VC will help us better identify our potential and set a course towards achieving it
There are grants available for academic collaborations with industry to facilitate invention commercialization. Universities such as UCI have recognized the potential of their research programs have organizations to help commercialize the discoveries of their scientists, and we may continue to look towards them for capital.
A thorough business plan could allow us to get a small business loan. However we currently believe this is a last resort. This is because the amount of funding we might gain might be less than with investors..
The pending patent is obviously an essential element to maingtaing our comptetitve edge The LCAT technology could certainly have future applications and uses and that patent is the key to benefiting from those. Our value proposition is based on three key parameters and they are speed, low cost and portability. The value we give our customers will not be abstract but based on figures of reduced cost and speed. Such well defined parameters allow us to present a clear value proposition to interested clients. Current comparable technology are FACS and MACS (Fluorescence/Magnetic Activated Cell Sorting). Comparing our prototype costs to the unit cost of a typical FACS unit, ours is at least half. MACS kits are currently slightly less expensive than prototype costs, however we expect unit cost to be significantly less should mass production be considered.